| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
20,145 |
18,844 |
$860K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
4,836 |
4,458 |
$465K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,838 |
5,392 |
$158K |
| 93000 |
|
16,996 |
16,150 |
$146K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,183 |
1,137 |
$130K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
8,070 |
7,243 |
$127K |
| 94060 |
|
3,640 |
3,473 |
$103K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
18,862 |
16,689 |
$99K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,318 |
2,001 |
$73K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
983 |
980 |
$57K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
747 |
742 |
$44K |
| 99401 |
|
1,833 |
1,754 |
$41K |
| 93925 |
|
446 |
423 |
$31K |
| 93922 |
|
1,106 |
1,055 |
$28K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,577 |
1,544 |
$19K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
210 |
202 |
$16K |
| 90756 |
|
607 |
592 |
$11K |
| 90674 |
|
640 |
629 |
$10K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
9,245 |
8,115 |
$9K |
| 90688 |
|
424 |
414 |
$8K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
943 |
925 |
$8K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
6,123 |
5,605 |
$7K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
4,919 |
4,080 |
$4K |
| 90658 |
|
221 |
220 |
$4K |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
553 |
551 |
$3K |
| L0631 |
Lumbar-sacral orthosis, sagittal control, with rigid anterior and posterior panels, posterior extends from sacrococcygeal junction to t-9 vertebra, produces intracavitary pressure to reduce load on the intervertebral discs, includes straps, closures, may include padding, shoulder straps, pendulous abdomen design, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise |
15 |
12 |
$2K |
| 96127 |
|
437 |
432 |
$1K |
| 81002 |
|
2,681 |
2,530 |
$1K |
| 99441 |
|
85 |
81 |
$984.18 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
322 |
291 |
$682.83 |
| 93880 |
|
16 |
16 |
$558.33 |
| 99442 |
|
13 |
12 |
$458.72 |
| J1940 |
Injection, furosemide, up to 20 mg |
327 |
320 |
$427.44 |
| 90662 |
|
22 |
20 |
$391.02 |
| G0008 |
Administration of influenza virus vaccine |
269 |
267 |
$307.43 |
| Q2037 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) |
12 |
12 |
$183.90 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
23,242 |
19,361 |
$127.65 |
| 99490 |
Ccm add 20min |
129 |
129 |
$79.43 |
| 3008F |
|
15,635 |
12,926 |
$20.00 |
| G8482 |
Influenza immunization administered or previously received |
1,450 |
1,421 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
1,011 |
946 |
$0.00 |
| 3078F |
|
2,639 |
2,157 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
3,928 |
3,562 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
449 |
435 |
$0.00 |
| 3077F |
|
1,059 |
881 |
$0.00 |
| 99072 |
|
1,452 |
1,300 |
$0.00 |
| G0030 |
Patient screened for tobacco use and received tobacco cessation intervention during the measurement period or in the six months prior to the measurement period (counseling, pharmacotherapy, or both), if identified as a tobacco user |
23 |
18 |
$0.00 |
| 4040F |
|
117 |
116 |
$0.00 |
| 4004F |
|
135 |
135 |
$0.00 |
| 3075F |
|
896 |
762 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
135 |
129 |
$0.00 |
| 3080F |
|
508 |
441 |
$0.00 |
| 3079F |
|
2,725 |
2,211 |
$0.00 |
| 1036F |
|
2,419 |
2,345 |
$0.00 |
| G8755 |
Most recent diastolic blood pressure >= 90 mmhg |
423 |
398 |
$0.00 |
| 3074F |
|
3,944 |
3,098 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
4,440 |
4,018 |
$0.00 |
| 3044F |
|
566 |
537 |
$0.00 |
| 3014F |
|
283 |
258 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
32 |
32 |
$0.00 |
| 3017F |
|
74 |
68 |
$0.00 |
| G9226 |
Foot examination performed (includes examination through visual inspection, sensory exam with 10-g monofilament plus testing any one of the following: vibration using 128-hz tuning fork, pinprick sensation, ankle reflexes, or vibration perception threshold, and pulse exam; report when all of the 3 components are completed) |
23 |
23 |
$0.00 |